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Abstract
We studied the regulation of brain acetyl CoA carboxylase (ACC) activity during food deprivation
and under the influence of hormones of glucose homeostasis: glucagon and insulin. Mice were
deprived of food and water for time periods of 1, 3, 6, 9, 12 and 24 hours and were then allowed
to re-feed for 5, 30 and 60 minutes. Mice that were deprived for up to 6 h, and then re-fed for 60
min, consumed the same amount of food compared to the ad libitum (control) animals. However,
after 9 h of deprivation, mice consumed only 50% of food present even after 1 h of re-feeding,
compared to the controls. The ACC activity was measured in the whole mouse brain of controls
and after 1, 3, 6, 9, 12, and 24 h of food deprivation. Brain extracts assayed from control mice
expressed an ACC activity of 0.988 ± 0.158 fmol/min/mg tissue without citrate and 0.941 ± 0.175
fmol/min/mg tissue with citrate. After 1 h of food deprivation, the total ACC activity without citrate
decreased to 0.575 ± 0.087 fmol/min/mg and in the presence of citrate, 0.703 ± 0.036 fmol/min/mg
activity was measured. The citrate-dependent ACC activity decreased over time, with only 0.478
± 0.117 fmol/min/mg of activity remaining after 24 h. Intraperitoneal (i.p.) injections of insulin,
glucagon and phosphate buffered saline (PBS) were performed and whole brain ACC activity
measured. After hormone administration, there were no significant differences in ACC activity in
the presence of citrate. However, in the absence of citrate, there was a significant 20% decrease in
ACC activity with glucagon (1.36 ± 0.09 fmol/min/mg) and a 33% increase with insulin (2.49 ± 0.11
fmol/min/mg) injections compared to PBS controls (1.67 ± 0.08 fmol/min/mg). Neuropeptide Y
(NPY) levels of corresponding brain extracts were measured by ELISA (OD) using anti-NPY
antibody and showed an 18% decrease upon insulin injection (0.093 ± 0.019) and a 50% increase
upon glucagon injection (0.226 ± 0.084) as compared to controls injected with PBS (0.114 ± 0.040).
Thus, we postulate that the changes in ACC levels under metabolic conditions would result in a
fluctuation of malonyl CoA levels, and subsequent modulation of NPY levels and downstream
signaling.
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Background
Acetyl CoA carboxylase (ACC) catalyzes the biotin-
dependent conversion of a acetyl CoA, HCO3
-, and ATP to
malonyl CoA [1]. Malonyl CoA serves as an activated C-2
donor compound during fatty acid (e.g. palmitic acid)
synthesis. The structure, function and regulation of ACC
have been studied extensively in relation to fatty acid syn-
thesis in liver [2-4]. There are two isoforms: ACC-1 of liver
is a cytosolic isoform, which has been associated with the
formation of malonyl CoA for fatty acid synthesis. The
specific enzyme activity of liver ACC isolated from fasted-
refed mice was approximately 0.3 units/mg. In the pres-
ence of 2 mM citrate (well above physiological concentra-
tions) the activity was stimulated to approximately 1.5
units/mg [5]. In contrast, ACC-2 is loosely bound to the
mitochondrial outer membrane and produces malonyl
CoA, which inhibits carnitine acyltransferase. Thus, the
malonyl CoA derived from ACC-2 serves as a regulator of
fatty acid β-oxidation and energy balance [6].
The role of ACC in brain is poorly understood. Brain does
not store fatty acids as an energy source. Brain tissue also
lacks the enzymes of β-oxidation. Nonetheless, the expres-
sion of mRNA for ACC (ACC 265) isoform has been
reported in developing rat brain as detected by northern
blot using total RNA [7]. In this paper we report the
expression of ACC-1 and ACC-2 in developing mouse
brain, identified by RT-PCR using Poly A+ RNA and the
respective isoform specific oligonucleotides primers (Fig
1). The raison d'être of malonyl CoA synthesis in brain by
ACC-1 may be explained by the existence of limited fatty
acid synthesis that occurs during development and tissue
regeneration. However, the expression of ACC-2 mRNA in
brain is a paradox, since brain cannot use fatty acids as a
fuel molecule; and therefore, has no need for carnitine
acyltransferase inhibition by malonyl CoA.
Citrate serves an allosteric activator of liver ACC causing it
to assume an active conformation [8]. Upon phosphor-
ylation of ACC by various kinases, ACC activity decreases
and the enzyme acquires citrate dependency for activa-
tion. Conversely, upon dephosphorylation by phos-
phatases, activity increases and ACC becomes less citrate-
dependent. In addition to being an allosteric activator of
ACC, citrate is also the source of acetyl CoA in cytoplasm
for fatty acid synthesis. Therefore, citrate is also an indirect
indicator of high cellular energy status [9]. The kinases
and the phosphatases are under hormonal influence. Glu-
cagon has been shown to activate the kinases and insulin
activates the phosphatases [2-4].
NPY and agouti-related protein (AgRP) are orexigenic
neuropeptides that regulate food intake (energy intake)
and energy expenditure. Pro-opiomelanocortin (POMC)
and cocaine-amphetamine-related transcript (CART) are
anorexigenic neuropeptides produced by the arcuate
nucleus (ARC) of the hypothalamus that also play a role
in energy intake and expenditure [10]. Cerulenin (a natu-
ral product) and C-75 are inhibitors of fatty acid synthase
(FAS) that cause the accumulation of malonyl CoA. In
lean mice, C-75 blocked food intake and prevented fast-
ing-induced up-regulation of hypothalamic AgRP and
NPY mRNAs, as well as down-regulation of CART and
POMC mRNA's [11].
In order for malonyl CoA to function as a regulator of
appetite-control feeding behaviours, the presence of the
RT-PCR of ACC-1 and ACC-2 in Mouse Brain and Liver Figure 1
RT-PCR of ACC-1 and ACC-2 in Mouse Brain and 
Liver. ACC-2 expression levels were much higher in mouse 
brain as compared to ACC-1, whereas in liver, both ACC-1 
and ACC-2 isoforms are expressed robustly. RT-PCR reac-
tion was performed according to the procedures of Invitro-
gen, Inc. The reaction contained 0.5 µg of mouse brain or 
liver poly A+ RNA (Clontech Inc.) and remaining components 
in quantities according to the manufacturer's procedure in a 
total volume of 50 µL. For ACC-1, the sense primer (cgaaa-
gactcttaactctgg) and anti-sense primer (ccaggttactgatctcatct) 
were used. For ACC-2, the sense primer (ggaagatgacagactc-
gaag) and anti-sense primer (tcatcagaggagttgtcatc) were used. 
Lane 1: low Mw marker. Lanes 2,4,6,7,9 and 11: empty. Lanes 
3 and 5: brain poly A+ RNA, RT-PCR products. Lanes 8 and 
10: liver poly A+ RNA, RT-PCR products. The expected 
product sizes were confirmed referring back to the full-
length cDNA.Nutrition & Metabolism 2006, 3:15 http://www.nutritionandmetabolism.com/content/3/1/15
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ACC isoform and its regulation in brain is mandatory
since malonyl CoA produced in the liver is unable to cross
the blood brain barrier. We measured total ACC enzy-
matic activities in adult whole mouse brain after various
periods of food deprivation. Here, we report the fluctua-
tion of brain ACC activity with food deprivation and the
influence of glucose homeostatic hormones: insulin and
glucagon. We postulate that the malonyl CoA formed in
brain by ACC may serve as a satiety sensor that would sub-
sequently signal the production of the orexigenic (NPY)
or anorexigenic (POMC) neurohormones that control
feeding behaviour.
Methods
Male BALB/c mice (retired breeders) were purchased from
Charles River Labs, Inc. (Wilmington, MA). Substrates:
ATP, acetyl CoA, sodium bicarbonate and hormones:
insulin and glucagon, as well as anti-NPY antibody were
purchased from Sigma-Aldrich, Inc. (St. Louis, MO). Radi-
ochemicals [14C] H14CO3
- for enzyme assays were pur-
chased from NEN Life Science Products (Boston, MA).
Laboratory Rodent Diet 5001 was purchased from Lab-
Diet. Protein detector ELISA kit, anti-rabbit ABTS systems
were purchased from Kirkegaard & Perry Laboratories, Inc.
RT-PCR
SuperScript One-Step RT-PCR with platinum Taq was
used for RT-PCR. Both cDNA synthesis and PCR were per-
formed in a single tube using gene specific primers and
Poly A+ RNA according to the procedures of Invitrogen,
Inc. Reaction contained 0.5 µg of mouse brain or liver
poly A+RNA and the remaining components to a final vol-
ume of 50 µL. For ACC-1, the sense primer (CGAAAGAT-
GACAGACTCGAAG) and anti-sense primer
(CCAGGTTACTGATCTCATCT) were used. For ACC-2, the
sense primer (GGAAGATGACAGACTCGAAG) and anti-
sense primer (TCATCAGAGGAGTTGTCATC) were used.
Reverse Transcription (RT) was done for 30 min at 55°C
using gene specific anti-sense primer to synthesize single
stranded cDNA. PCR was performed on a Perkin-Elmer
thermocycler. Thermal cycle phase consisted of 35 cycles
of denaturation at 94°C for 15 s, annealing at 45°C for 30
s and extension at 68°C for 15 min. Final extension was
performed for 10 min at 72°C. The PCR products were
resolved on a 1% agarose gel electrophoresis using 1×
TAE. The expected product sizes were confirmed referring
back to the DNA sequences of the full-length cDNA.
Starvation regimens
Mice in the experimental groups were subjected to depri-
vation regimens of 1, 3, 6, 9, 12 and 24 h by removing
food, water and bedding. The water and the bedding were
removed to emulate complete deprivation. In the control
groups (ad libitum), food, water and bedding remained in
the cages, the mice exhibiting normal feeding activity
throughout the 24 h time period. The animals were ini-
tially placed one mouse/cage. To normalize diurnal varia-
tions, mice were initially exposed to 4 days of standard 12
h light/12 h dark cycles immediately upon receiving the
shipment from the breeder. All groups were started with a
12 h dark cycle. Three mice were included in each group.
Mice were gently asphyxiated by subjecting them to CO2,
the whole brain carefully dissected and the tissues imme-
diately frozen to -80°C prior to homogenization.
Hormone injections
Mice (N = 4/group) were injected with 25 µU insulin in
0.2 mL and 2.5 µU glucagon in 0.2 mL via i.p. injection.
Controls received PBS. For insulin-glucagon challenge
group, glucagon (2.5 µU/0.2 mL) proceeded insulin (25
µU/0.2 mL) injection 20 min after initial injection. The
insulin, glucagon and PBS groups were sacrificed after 20
min and the whole brain dissected, quickly frozen and
used as needed. The insulin-glucagon challenge group was
sacrificed after 40 min and the whole brain dissected and
Mass of Food Consumed during Timed Re-Feeding Periods  Following Food Deprivation in the BALB/C mouse Figure 2
Mass of Food Consumed during Timed Re-Feeding 
Periods Following Food Deprivation in the BALB/C 
mouse. Food deprivation for up to 6 h, and then re-fed for 
60 min consumed the same amount of food compared to the 
ad libitum (control) animals. However, after 9 h of depriva-
tion, mice consumed only 50% of food present even after 1 h 
of re-feeding, compared to the controls. Retired male BALB/
C breeder mice (n = 3/group) were deprived of food (Lab-
Diet Rodent Diet 5001), water and bedding for periods of 1, 
3, 6, 9, 12, and 24 h. Subsequently, re-feeding for 5, 30 and 60 
min duration was carried out and the mass of food consumed 
during these periods was determined and compared to the 
mass of food consumed by the ad libitum controls. The analy-
sis of variance revealed a significant difference in the ad libi-
tum Control [F(5,12) = 192.67, p < 0.001], 30 min refeeding 
[F(5,12) = 5.87, p < 0.006] and 60 min refeeding [F(5,12) = 
16.40, p < 0.001] groups. No significance was found in the 5 
min refeeding group upon deprivation [F(5,12) = 1.19, p = 
0.370].
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stored as in other groups. From the brain tissues, ACC
activities were assayed as explained below.
ACC activity assay
Tissues were ground in a total of 350 µL homogenization
buffer [100 mM Tris-HCl (pH 8.0) containing 1 mM DTT,
1 mM EDTA, and 100 µL/100 mL of protease inhibitor
cocktail (Calbiochem, Inc.)] and extracts centrifuged at
2128 × g for 5 min at 5°C. Aliquots from the supernatants
were assayed using 10 µL of assay buffer [5.0 mM HEPES,
0.25 mM MnCl2, 0.2 mM DTT, 0.01235 mM acetyl CoA,
0.4 mM ATP, 0.05 mM citrate or replaced with water,
0.075 mg/mL BSA, 2.51 mM NaHCO3
- (containing 1.11 ×
105 cpm/nmol)] added to 10 µL of tissue extracts or
homogenization buffer and the reaction was incubated
for 1 h at 37°C. The reaction was stopped by adding 5 µL
of 1N HCl. The contents were then dried, re-suspended in
100 µL H2O and the radioactivity was determined using a
liquid scintillation spectrometer. For each extract, ACC
activity assays were performed in duplicates. The ACC
activity was expressed in fmol/min/mg of brain tissue.
Indirect antibody ELISA
Indirect antibody ELISA was performed according to the
procedures of Kirkegaard & Perry Laboratories, Inc.
Briefly, 2 µL of the antigens (brain extracts) were coated
on to the appropriate wells by incubation overnight at
37°C. The plates were then emptied and blocked with 1×
BSA for 1 h. The emptied plates were then reacted with
1:500 dilutions of rabbit anti-NPY primary antibody for 1
h at room temperature. The plates were washed three
times with 1× wash solution and then reacted with sec-
ondary antibody-conjugated with alkaline phosphatase at
a dilution of 1:5000 for 1 h at room temperature. The
plates were washed three times with 1× wash buffer and
reacted with substrate for colour development. Once the
visible colour was developed, the reaction was stopped
with stop solution. The plate was then read for optical
density (OD) at 405 nm using Perkin Elmer Wallac 1420
VICTOR3 Multilabel Counter. For negative controls, the
samples were not reacted with primary anti-NPY anti-
body. For blanks, the extracts were substituted with extract
buffer. The net OD values for samples were obtained by
subtracting the individual values with negative control
values.
Statistical analysis
For each time point, brain extracts from four animals were
assayed independently. Assays were then performed in
duplicates and averaged. The value in each time point rep-
resents an N of four. Enzyme activity for each was calcu-
lated and quantitative results are expressed as mean ±
standard deviation (SD). Comparisons of ACC enzymatic
activity groups of mouse brain homogenates were per-
formed by one-tailed Student's t-test and by single factor
analysis of variance (ANOVA), where appropriate.
Results
RT-PCR
The presence of two isoforms of ACC in mouse brain was
established (Fig 1) by RT-PCR. In mouse brain, ACC-2
expression levels were much higher than levels of ACC-1
whereas, in liver, both ACC-1 and ACC-2 isoforms are
expressed robustly (Fig 1). Having established the pres-
ence of ACC in mouse brain we were interested in finding
the role of this enzyme in relation to food deprivation.
Re-feeding after food deprivation
We studied food consumption in adult mice after various
periods of deprivation. Ad libitum controls consumed
about 1 g of food/h continuously throughout the 24 h
experimental time period. Experimental groups that were
deprived of food, water and bedding for 1–6 h consumed
nearly the same amount of food as controls within 1 h of
re-feeding. However, after 9 h of deprivation (deprivation
between 9–24 h) the mice consumed only about 50% of
food compared to ad libitum controls even after 1 h of re-
feeding (Fig 2).
Table 1: ACC Activity in Whole Brain under Food Deprivation. Summary of data showing the ACC activity with and without citrate of 
ad libitum (controls) and upon 1 h, 3 h, 6 h, 9 h, 12 h, and 24 h deprivation. Each value represents an average of activities from brain 
extracts of four separate animals. Each extract was assayed in duplicate. Values presented as mean ± SD. A one-way analysis of 
variance revealed significant differences between the groups in the presence of citrate [F(6,21) = 4.47, p < 0.001] and in the absence of 
citrate, [F(6,21) = 3.54, p < 0.01]).
Deprivation Regimen Time (hours) ACC Activity without Citrate (fmol/min/
mg tissue) ± SD
ACC Activity with Citrate (fmol/min/mg 
tissue) ± SD
1 0.575 ± 0.087 0.703 ± 0.036
3 0.457 ± 0.117 0.607 ± 0.062
6 0.495 ± 0.178 0.628 ± 0.057
9 0.473 ± 0.138 0.597 ± 0.156
12 0.543 ± 0.089 0.558 ± 0.066
24 0.555 ± 0.053 0.478 ± 0.117
Ad libitum (control) 0.988 ± 0.158 0.941 ± 0.175Nutrition & Metabolism 2006, 3:15 http://www.nutritionandmetabolism.com/content/3/1/15
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Effect of food deprivation on brain ACC activity
In ad libitum control animals, the ACC activity assayed
without citrate was 0.988 (± 0.158) fmol/min/mg and
was nearly unchanged in the presence of citrate (0.941 ±
0.175 fmol/min/mg) (Table 1). After 1 h of deprivation,
the activity without citrate dropped significantly to 0.575
(± 0.087) fmol/min/mg and the activity with citrate was
0.703 (± 0.036) fmol/min/mg (Table 1). ACC activity
without citrate remained nearly constant throughout all
the deprivation regimens (1–24 h) exhibiting 0.555 (±
0.053) fmol/min/mg at 24 h deprivation (Fig 3a). How-
ever, ACC activity in the presence of citrate, from 1 h to 24
h decreased gradually to 0.478 (± 0.117) fmol/min/mg.
When ACC activity with citrate at 1 h was compared with
24 h of deprivation, there is a statistically significant 32%
reduction in activity (Fig 3b).
Hormonal regulation of brain ACC activity
In order to understand the regulation of brain ACC activ-
ity by hormones of glucose homeostasis, we measured the
ACC activity shortly after the administration of glucagon
and insulin. We injected (i.p.) groups of mice with gluca-
gon (2.5 µUnits, [12.5 ng/ml]/animal), insulin (25
µUnits, [125 ng/ml]/animal), and insulin challenged with
glucagon. Control mice were injected with PBS. ACC
activity assayed in the presence of citrate in the PBS-
injected control group was 1.67 ± 0.08 fmol/min/mg. In
the insulin-injected groups, the ACC activity was 2.49 ±
0.11 fmol/min/mg. Glucagon-injected mice exhibited
ACC activity of 1.36 ± 0.09 fmol/min/mg. The insulin-
glucagon challenge group exhibited ACC activity of 1.96 ±
0.14 fmol/min/mg (Fig 4a). When the ACC activity assays
contained citrate the activity varied only minimally rang-
ing from 1.56 ± 0.10 – 1.78 ± 0.16 fmol/min/mg (Fig 4b).
Spectrophotometric Quantification of NPY
The same extracts used for hormonal regulation of brain
ACC activity measurements were utilized for the determi-
nation of NPY levels using an indirect antibody ELISA
method with rabbit anti-NPY antibody. The relative val-
ues of NPY in terms of OD are presented (Fig 5). It is
apparent from these results that, when compared to PBS
controls (0.114 ± 0.040), extracts from insulin-adminis-
tered groups possessed a modest decrease in NPY levels
(0.093 ± 0.019). In contrast, NPY levels increased almost
50% in the glucagon-administered extracts (0.226 ±
0.084).
Discussion
When mice were deprived of food, water, and bedding for
up to 6 h, they retained the appetite to consume the same
amount of food as controls when allowed to re-feed for 1
h. However, after 6 h of deprivation (between 9–24 h),
when allowed to re-feed for up to 1 h, only 50% of the
available food was consumed. This is quite interesting in
ACC Activity in Whole Brain during Food Deprivation Figure 3
ACC Activity in Whole Brain during Food Depriva-
tion. 3a (ACC, assayed without citrate). 3b (ACC, assayed 
with 0.05 mM citrate). The ACC activity without citrate ini-
tially decreased by 42% with no significant change between 1 
h and 24 h of deprivation. In the presence of citrate, the 
ACC activity decreased gradually over 24 h with a significant 
32% decrease at 24 h deprivation. ACC activity assayed with 
and without citrate of ad libitum (controls), 1 h deprivation, 
and 24 h deprivation groups are represented. Whole brain 
was dissected, homogenized and the extracts were assayed 
for ACC activity in the presence or absence of citrate. The 
ACC activity assay mixture contained 5.0 mM HEPES, 0.25 
mM MnCl2, 0.2 mM DTT, 0.01235 mM acetyl CoA, 0.4 mM 
ATP, 0.075 mg/mL BSA, 2.51 mM NaHCO3
- (containing 1.11 
× 105 cpm/nmol) as described in detail in the methods sec-
tion. Results are expressed as the mean ± SD of assays of the 
brain extracts from four independent animals. Each extract 
was assayed in duplicate. A one-way analysis of variance 
revealed significant differences in the presence of citrate 
between 1 h and 24 h deprivation [F(2,6) = 9.89, p < 0.012]. 
When citrate was absent, significant differences between 
groups were also present [F(2,9) = 7.24, p < 0.013], how-
ever, no statistical significant was shown specifically between 
the 1 h starvation and 24 h starvation groups.
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that feeding behaviour appears retained for up to 6 h after
deprivation (Fig 2). Thereafter, some mechanism inhibits
the animals' ability to fully feed, unlike continuously fed
control animals (1 g of food/h). We speculate that under
periods of deprivation, mice become adapted to the lack
of food and water by slowing their physiological processes
in order to limit energy intake. It is interesting that this
feeding behaviour in mice is manifested only after 6 h of
deprivation. The biochemical basis of this process is not
clearly understood.
When we performed RT-PCR using oligonucleotides that
are specific to ACC-1 and ACC-2 isoforms with poly A+
mRNA from developing brain, we identified the presence
of both ACC-1 and ACC-2 transcripts. RT-PCR shows that
the levels of ACC-1 are higher in liver than in brain while
the levels of ACC-2 are nearly similar in two tissues (Fig
1). Liver is the major tissue that synthesizes fatty acids
and, therefore, the role of high ACC-1 levels is clear. It is
known that the cytosolic ACC-1 isoform produces the
committed metabolite malonyl CoA that is channelled for
de novo synthesis of palmitic acid. In contrast, the isoform
ACC-2 that is loosely bound to the inner mitochondrial
membrane has been purported to produce malonyl CoA
that is involved in regulating the β-oxidation of fatty acid
by inhibiting carnitine acyl transferase. Therefore, the
presence of both isoforms ACC-1 and ACC-2 in liver tis-
sue makes logical sense.
The expression of ACC-1 and ACC-2 in brain is an
enigma. One might speculate that the expression of ACC-
1 in brain is necessary since adult brain undergoes tissue
regeneration (or neuronal regeneration) and this would
imply a role of increased fatty acid synthesis. Nonetheless,
the expression of ACC-2 in brain is a paradox since brain
cannot use fatty acids as fuel. Therefore, an alternate
explanation is warranted. We hypothesized that malonyl
CoA produced by ACC-2 in brain tissues may be involved
in the regulation of satiety and feeding. The role of glucose
homeostatic hormones and ensuing discussion on the
hormonal regulation of brain ACC was first presented by
our lab [12]. Others have discussed the role of malonyl
CoA in NPY regulation [13].
C-75 is a fatty acid synthase (FAS) inhibitor that causes the
accumulation of malonyl CoA whereas TOFA is an ACC
inhibitor, which results in the reduction of malonyl CoA
synthesis. Using these inhibitors, changes in the in vivo
levels of malonyl CoA may be elicited. It has been found
that malonyl CoA concentrations correlated with mRNA
expression of hypothalamic neuropeptides NPY and
POMC [11]. It was also demonstrated that upon treat-
ment with FAS inhibitors (C-75) there was reduced food
intake and body weight in mice as well as increased mal-
onyl CoA [14]. The role of malonyl CoA in relation to
Whole Brain ACC Activity Following Intraperitoneal Injec- tion of PBS, Glucagon, Insulin and Insulin-Glucagon Challenge Figure 4
Whole Brain ACC Activity Following Intraperitoneal 
Injection of PBS, Glucagon, Insulin and Insulin-Gluca-
gon Challenge. Figure 4a (ACC, assayed without citrate). 
Figure 4b (ACC assayed, with 0.05 mM citrate). ACC activity 
in glucagon injected mice decreased significantly in the 
absence of citrate and increased in the presence of citrate. 
ACC activity in insulin injected mice shows activity regard-
less of citrate presence. Retired male, BALB/C breeder mice 
received intra-peritoneal (i.p) injection of glucagon (2.5 µU in 
0.2 mL) or insulin (25 µU in 0.2 mL). Controls received PBS. 
For insulin-glucagon challenge group, 20 min after insulin (25 
µU/0.2 mL) injection, they received glucagon (2.5 µU/0.2 mL) 
injection. Whole brain was dissected, homogenized and the 
extracts were assayed for ACC activity in the absence of cit-
rate. Each extract was assayed in duplicate. The ACC activity 
assay mixture contained, 5.0 mM HEPES, 0.25 mM MnCl2, 0.2 
mM DTT, 0.01235 mM acetyl CoA, 0.4 mM ATP, 0.075 mg/
mL BSA, 2.51 mM NaHCO3
- (containing 1.11 × 105 cpm/
nmol). Results are expressed as the mean ± SD of assays of 
the brain extracts from four independent animals. A one-way 
analysis of variance revealed no significant differences in the 
presence of citrate between among the injection groups 
[F(3,12) = 1.01, p = 0.422]. When citrate was absent, signifi-
cant differences between groups were found to be present 
[F(3,12) = 5.60, p < 0.012].
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energy balance was clearly demonstrated by many authors
in other tissues [15]. Taken together, it is reasonable to
suggest that malonyl CoA may alter feeding patterns
through NPY and POMC concentrations. Using rat brain,
the ACC activity was measured over a period of develop-
ment ranging from 0.7 months to 18 months and it was
found that ACC activity decreased from 0.026 µMols/min
to 0.015 µMols/min [16]. Others have also shown
changes in the activities of lipogenic enzymes in the
brains of developing rats during development [17]. One
can assume that in adult brain the contribution by the
ACC-1 activity would be minimal, since there is very little
myelin synthesis.
Nonetheless, changes in brain ACC activity in response to
deprivation of varying lengths of time, and in relation to
alterations in feeding behaviour during the subsequent re-
feeding has not been previously examined. The liver ACC
enzyme, upon phosphorylation, becomes more citrate-
dependent for catalytic activity [3]. We hypothesized that
a similar mechanism may occur with the brain enzyme. In
this paper, we are the first to describe the role of the allos-
teric effector, citrate, on brain ACC activity. Since TCA
cycle is very active in brain mitochondria this metabolite
would be easily available to allosterically regulate the
ACC-2 bound to the inner mitochondrial membrane. It is
practically impossible to distinguish the two activities of
the isoforms of ACC-1 and ACC-2 in crude extracts since
it would be a mixture of both isoforms. A separation of
the two activities would result in a loss of quantitation.
Therefore, in this paper we report the total ACC activity in
whole brain under various time periods of food depriva-
tion as well as its regulation by the glucose homeostatic
hormones. We also examine the fluctuation of NPY and
its correlation to metabolic status.
The observation that, in control mice, ACC activity with
and without citrate remained nearly unchanged shows
that under normal or non-deprived conditions ACC
behaves like a dephosphorylated citrate-independent
form. After 1 h of food deprivation there was an abrupt
decrease (~42%) in ACC activity in the absence of citrate
and over 24 h of food deprivation the ACC activity contin-
ued to drop only minimally (<5%) (Fig 3a and Table 1).
In contrast, ACC activity measured in the presence of cit-
rate showed a gradual decrease in ACC activity over 24 h
of deprivation (Fig 3b and Table 1) suggesting that ACC
undergoes covalent modification by phosphorylation cat-
alyzed by cAMP kinase. Phosphorylated ACC is usually
citrate dependent but it appears that, over 24 h of depriva-
tion, ACC becomes hyper-phosphorylated, such that even
Hypothesis of Neurohormonal Signalling During Deprivation Figure 6
Hypothesis of Neurohormonal Signalling During 
Deprivation. Upon food deprivation, glucagon reaches a 
threshold level to activate the ACC-kinase. ACC-kinase 
phosphorylates ACC making it a less active citrate depend-
ent species. Due to less active ACC, malonyl CoA levels 
drop, resulting in increased NPY expression. NPY subse-
quently promotes feeding.
NPY Indirect Antibody ELISA Figure 5
NPY Indirect Antibody ELISA. NPY measured in the 
insulin injection groups decreased 18% and in the glucagon 
injection groups increased 50% when compared to NPY lev-
els of controls injected with PBS. Indirect antibody ELISA was 
performed according to the procedures of Kirkegaard & 
Perry Laboratories, Inc., using rabbit anti-NPY antibody. The 
NPY levels were determined through color intensity by 
measuring OD reading at 405 nm using a Perkin Elmer Wal-
lac 1420 VICTOR3 Multilabel Counter. Results are 
expressed as the mean ± SD of assays of the brain extracts 
from four independent animals. Each extract was assayed in 
duplicate. For negative controls, the samples were not 
reacted with primary anti-NPY antibody. The net OD values 
for samples were obtained by subtracting the individual val-
ues with negative control values. The average of net OD val-
ues were converted into % change in NPY levels relative to 
PBS control and is plotted. A one-way analysis of variance 
revealed significant differences between the groups [F(3,12) 
= 4.13, p = 0.031].
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in the presence of citrate its activity remains lower and is
essentially citrate-independent. Based on results by
Shimokawa et al. [11] the expected drop in malonyl CoA,
would stimulate the expression of mRNA for the orexi-
genic hormone, NPY.
Results from our food deprivation experiments clearly
demonstrated that fluctuations in brain ACC activity cor-
related with metabolic status. The decrease in ACC activity
with glucagon may be explained by the glucagon-induced
increase in cAMP-dependent kinase activity. The kinase
would be expected to phosphorylate ACC, rendering it
inactive and citrate-dependent. Upon citrate binding, the
phosphorylated species becomes more active and this was
observed in our results (Fig 4b). Under the influence of
insulin one would expect the phosphatases to be more
active, re-activating ACC to its citrate-independent form.
The results show that NPY levels in extracts from the glu-
cagon injection group (0.226 ± 0.084) indicate a 50%
increase in NPY when compared to PBS controls (0.114 ±
0.040) whereas the insulin injection group contained
approximately 18% less NPY (0.093 ± 0.019) relative to
controls (Fig 5). Thus, we postulate (Fig 6) that in the
presence of glucagon, cAMP kinase phosphorylates ACC
and converts it into a less active citrate-dependent species
leading to decreased malonyl CoA and a subsequent rise
in NPY levels. Increased NPY levels could then signal feed-
ing behaviour. In future studies, we will be determining
the NPY levels under various deprivation regimens in
order to better understand the role of brain ACC with ref-
erence to the satiety and feeding.
Conclusion
After a period of food deprivation for up to 6 h, mice were
able to consume equal amounts of food within 1 h of re-
feeding as compared to matched ad libitum controls. How-
ever, a period of deprivation from 9–24 h caused a 50%
reduction in the consumption of food even after 1 h of re-
feeding. ACC activity in brain fluctuates according to food
deprivation. In addition, the hormones of glucose home-
ostasis (glucagon and insulin) may reciprocally modulate
brain ACC activity. We have shown that an elevated gluca-
gon level leads to lower ACC activity and increased NPY
levels in brain. Conversely, an elevated insulin level leads
to higher ACC activity and decreased NPY levels. Based on
these results, we hypothesize that under periods of food
deprivation glucagon levels in brain increase, stimulating
cAMP dependent protein kinase. The kinase phosphor-
ylates ACC in vivo converting ACC into a less active citrate-
dependent form. Due to the gradual disappearance of this
phosphorylated/citrate-dependent ACC species over time,
there is an absolute decrease in malonyl CoA levels, corre-
lating to the purported increase in NPY expression and the
consequent promotion of feeding (Fig 6).
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